These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2031317)

  • 21. Interleukin-2 activated lymphocytes show improved sensitivity for class 1 HLA typing.
    Hirose M; Shinohara K; Watanabe H; Lee E; Kuroda Y
    Tokushima J Exp Med; 1996 Dec; 43(3-4):87-91. PubMed ID: 9100455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complexity of the supertypic HLA-DRw53 specificity: two distinct epitopes differentially expressed on one or all of the DR beta-chains depending on the HLA-DR allotype.
    Knowles RW; Flomenberg N; Horibe K; Winchester R; Radka SF; Dupont B
    J Immunol; 1986 Oct; 137(8):2618-26. PubMed ID: 2428870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Membrane expression and synthesis of p23,30 (HLA-DR antigen) by human peripheral blood monocytes.
    McKinney TK; Boto WO; Spiro RC; Humphreys RE
    Exp Hematol; 1980 Jul; 8(6):709-16. PubMed ID: 6162660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In situ immune complexes, lymphocyte subpopulations, and HLA-DR-positive epithelial cells in Hashimoto thyroiditis.
    Aichinger G; Fill H; Wick G
    Lab Invest; 1985 Feb; 52(2):132-40. PubMed ID: 3881622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative analysis of serologic typing and HLA-II typing by micro-PCR-SSP].
    Wu DL; Ling HX; Ding H; Zhang Y
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Mar; 22(3):247-9. PubMed ID: 12390779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Constitutive intracellular expression of human leukocyte antigen (HLA)-DO and HLA-DR but not HLA-DM in trophoblast cells.
    Ranella A; Vassiliadis S; Mastora C; Valentina M; Dionyssopoulou E; Athanassakis I
    Hum Immunol; 2005 Jan; 66(1):43-55. PubMed ID: 15620461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Automated reading of Propidium Iodide lymphocytotoxicity tests for HLA-DR, MB, MT typing.
    Naipal AM; D'Amaro J; Bruning JW; van Leeuwen A; van Rood JJ
    Tissue Antigens; 1984 Nov; 24(5):302-6. PubMed ID: 6597977
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A simple and rapid method for the detection of lymphocytotoxic antibodies using cell panels frozen on Terasaki plates.
    Sinnott PJ; Kippax RL; Sheldon S; Dyer PA
    Tissue Antigens; 1985 Nov; 26(5):318-22. PubMed ID: 3867177
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of chloroquine on lymphocytic HLA-A and B antigens].
    Májský A
    Cas Lek Cesk; 1992 Sep; 131(18):560-3. PubMed ID: 1394377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocytotoxicity inhibition: a reliable method for HL-A typing of cultured cell lines.
    Bias WB; Borgaonkar DS; Kucherlapati RS; Ruddle FH
    Birth Defects Orig Artic Ser; 1975; 11(3):71-6. PubMed ID: 1203507
    [No Abstract]   [Full Text] [Related]  

  • 31. HLA-DR typing: some relevant difficulties.
    Borelli I; Cornaglia M; Olivetti E; Curtoni ES
    Transplant Proc; 1979 Jun; 11(2):1319-20. PubMed ID: 89736
    [No Abstract]   [Full Text] [Related]  

  • 32. Variations of the lymphocytotoxicity test. An evaluation of sensitivity and specificity.
    Zachary AA; Klingman L; Thorne N; Smerglia AR; Teresi GA
    Transplantation; 1995 Sep; 60(5):498-503. PubMed ID: 7676500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Automated measurement of cell destruction with the Patimed System in comparison with conventional HLA typing].
    Wimmer A; Graf A; Wank R
    Beitr Infusionsther; 1992; 30():349-53. PubMed ID: 1284732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The development of cytotoxic T lymphocytes in HLA-D/DR identity].
    Porubská S; Buc M; Bencová M; Nyulassy S; Stefanovic J
    Bratisl Lek Listy; 1989 Feb; 90(2):115-9. PubMed ID: 2785838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Technique for automating HLA-DR typing].
    Teuliere MF; Fizet D; Ferrer AM; Vezon G
    Rev Fr Transfus Hemobiol; 1991 May; 34(3):243-7. PubMed ID: 1712203
    [TBL] [Abstract][Full Text] [Related]  

  • 36. B-lymphocyte typing (HLA-DR, MT, MB) interlaboratory reproducibility.
    Singh G; Griffin M
    Am J Clin Pathol; 1983 May; 79(5):569-73. PubMed ID: 6601456
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HLA-DR typing of frozen B lymphocytes.
    Madsen M; Johnsen HE; Kissmeyer-Nielsen F
    Transplant Proc; 1979 Jun; 11(2):1321. PubMed ID: 314177
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies on HLA-DR typing method --micro lymphocyte cytotoxicity test (author's transl)].
    Shiwaku Y; Morita N; Shingami T; Mori H; Nakao Y; Hashimoto S
    Igaku Kenkyu; 1979 Sep; 49(3):227-35. PubMed ID: 547637
    [No Abstract]   [Full Text] [Related]  

  • 39. Decreased expression of HLA-DR antigens on monocytes in patients with multiple sclerosis.
    Baxevanis CN; Reclos GJ; Arsenis P; Anastasopoulos E; Katsiyiannis A; Lymberi P; Matikas N; Papamichail M
    J Neuroimmunol; 1989 May; 22(3):177-83. PubMed ID: 2649510
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition of a non-HLA-ABC antigen present on B and T lymphocytes and monocytes only detectable with the indirect immunofluorescence test.
    Décary F; Verheugt FW; van Helden-Henningheim L; von Riesz E; Schreuder-van Gelder R; von dem Borne AE; Engelfriet CP
    Vox Sang; 1979; 36(3):150-8. PubMed ID: 88812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.